CIK: 1612372 - Address: C/O Vaxart, Inc., 170 Harbor Way, Suite 300, South San Francisco, CA 94080
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/31/25 20:38
7/29/25
VXRTVaxart, Inc.DEHealthBioPrdBiological Products, (No DiagWatson W. MarkCADP40.405001011104D
6/20/24 06:10
6/18/24
VXRTVaxart, Inc.DEHealthBioPrdBiological Products, (No DiagWatson W. MarkCADP140.67890203478D
12/28/22 17:25
12/28/22
VXRTVaxart, Inc.DEHealthBioPrdBiological Products, (No DiagWatson W. MarkCADP150.7570020New20D
1/31/22 18:06
1/27/22
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsWatson W. MarkNCDM.d00.0008991D
8/10/21 18:21
8/6/21
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsWatson W. MarkNCDM.d00.000305783D
8/19/20 16:30
8/17/20
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsWatson W. MarkNCDS-675.180-13-2053D
8/11/20 16:51
8/7/20
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsWatson W. MarkNCDM.d00.000308366D
3/30/20 14:54
3/30/20
SYKESykes Enterprises IncFLTechSoftwComputer Integrated Systems DWatson W. MarkFLDS-7826.100-3-336D
8/15/19 16:29
8/13/19
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsWatson W. MarkNCDM.d00.0002522036D
8/16/18 17:00
8/14/18
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsWatson W. MarkNCDM.d00.0001064911D
3/10/17 16:19
3/8/17
HPPIHedgepath Pharmaceuticals, Inc.DEHealthBiolabCommercial Physical & BiologiWatson W. MarkFLDM.d00.000900554D
9/9/14 17:00
9/8/14
HPPIHedgepath Pharmaceuticals, Inc.DEHealthBiolabCommercial Physical & BiologiWatson W. MarkFLDP10.1300010New10D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact